131 related articles for article (PubMed ID: 9034285)
1. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats.
Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
Am J Hematol; 1997 Feb; 54(2):118-23. PubMed ID: 9034285
[TBL] [Abstract][Full Text] [Related]
2. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation.
Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
Am J Physiol; 1996 Sep; 271(3 Pt 1):L470-5. PubMed ID: 8843797
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486
[TBL] [Abstract][Full Text] [Related]
5. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
[TBL] [Abstract][Full Text] [Related]
7. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.
Uchiba M; Okajima K; Murakami K; Johno M; Mohri M; Okabe H; Takatsuki K
Am J Physiol; 1997 Oct; 273(4):L889-94. PubMed ID: 9357866
[TBL] [Abstract][Full Text] [Related]
8. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Am J Physiol; 1997 Feb; 272(2 Pt 1):L197-202. PubMed ID: 9124369
[TBL] [Abstract][Full Text] [Related]
11. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
Murakami K; Okajima K; Uchiba M; Johno M; Okabe H; Takatsuki K
Thromb Haemost; 1996 Jun; 75(6):965-70. PubMed ID: 8822594
[TBL] [Abstract][Full Text] [Related]
12. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
Uchiba M; Okajima K
Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
[TBL] [Abstract][Full Text] [Related]
14. ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin.
Imada K; Takahashi Y; Hosaka Y; Adachi T; Niina H; Mochizuki H
Blood Coagul Fibrinolysis; 1999 Dec; 10(8):503-11. PubMed ID: 10636462
[TBL] [Abstract][Full Text] [Related]
15. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats.
Uchiba M; Okajima K; Murakami K
Thromb Res; 1998 Mar; 89(5):233-41. PubMed ID: 9645917
[TBL] [Abstract][Full Text] [Related]
16. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.
Taylor FB; Chang AC; Peer GT; Mather T; Blick K; Catlett R; Lockhart MS; Esmon CT
Blood; 1991 Jul; 78(2):364-8. PubMed ID: 2070073
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.
Mizutani A; Okajima K; Uchiba M; Noguchi T
Blood; 2000 Jun; 95(12):3781-7. PubMed ID: 10845910
[TBL] [Abstract][Full Text] [Related]
18. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
19. [Thrombomodulin].
Ohmori Y; Takahashi Y
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
[TBL] [Abstract][Full Text] [Related]
20. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
